Company Overview of GenPharm International, L.L.C
GenPharm International, Inc. engages in the development and application of HuMAb-Mouse transgenic animal technology. Its technology is used in the creation of human monoclonal antibodies for therapeutic uses. The company was founded in 1989 and is based in San Jose, California. As of October 21, 1997, GenPharm International, Inc. was a subsidiary of Medarex, Inc. Later, it operates as a subsidiary of Bristol-Myers Squibb Company.
2350 Qume Drive
San Jose, CA 95131
Founded in 1989
Key Executives for GenPharm International, L.L.C
Similar Private Companies By Industry
|Sentilus, Inc.||United States|
|JRX Biotechnology, Inc.||United States|
|NOSTOC Corporation||United States|
|Kinexum Metabolics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact GenPharm International, L.L.C, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.